Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Pohl

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Wiener Medizinische Wochenschrift (1946)|May 12, 2005
[The pathobiology of COPD]Wolfgang Pohl
Respiratory Medicine|April 26, 2021
TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPDKatharina Marth, Andreas Renner, Wolfgang Pohl
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|November 25, 2016
[Preclinical birth of an extremely premature infant - a case report]Tobias Pöhlmann, Armin Schmidt, Wolfgang Pohl
Respiratory Medicine|March 24, 2015
Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPDKatharina Marth, Elisabeth Schuller, Wolfgang Pohl
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 11, 2020
COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case studyAndreas Renner, Katharina Marth, Karin Patocka, et al.
Immunity, Inflammation and Disease|May 7, 2021
Dupilumab rapidly improves asthma control in predominantly anti-IL5/IL5R pretreated Austrian real-life severe asthmaticsAndreas Renner, Katharina Marth, Karin Patocka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2012
Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPDMilos Petrovic, Michael Reiter, Harald Zipko, et al.
ERJ Open Research|December 1, 2020
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia mythAndreas Renner, Katharina Marth, Karin Patocka, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2020
Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life dataAndreas Renner, Katharina Marth, Karin Patocka, et al.
Therapeutic Advances in Respiratory Disease|April 10, 2016
Treatment response according to small airway phenotypes: a real-life observational studyKatharina Marth, Monica Spinola, Judith Kisiel, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Wiener Medizinische Wochenschrift (1946)|May 12, 2005
[The pathobiology of COPD]Wolfgang Pohl
Respiratory Medicine|April 26, 2021
TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPDKatharina Marth, Andreas Renner, Wolfgang Pohl
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|November 25, 2016
[Preclinical birth of an extremely premature infant - a case report]Tobias Pöhlmann, Armin Schmidt, Wolfgang Pohl
Respiratory Medicine|March 24, 2015
Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPDKatharina Marth, Elisabeth Schuller, Wolfgang Pohl
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 11, 2020
COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case studyAndreas Renner, Katharina Marth, Karin Patocka, et al.
Immunity, Inflammation and Disease|May 7, 2021
Dupilumab rapidly improves asthma control in predominantly anti-IL5/IL5R pretreated Austrian real-life severe asthmaticsAndreas Renner, Katharina Marth, Karin Patocka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2012
Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPDMilos Petrovic, Michael Reiter, Harald Zipko, et al.
ERJ Open Research|December 1, 2020
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia mythAndreas Renner, Katharina Marth, Karin Patocka, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2020
Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life dataAndreas Renner, Katharina Marth, Karin Patocka, et al.
Therapeutic Advances in Respiratory Disease|April 10, 2016
Treatment response according to small airway phenotypes: a real-life observational studyKatharina Marth, Monica Spinola, Judith Kisiel, et al.
Pageof 5